Do not diagnose CKD in people with: an eGFRcreatinine of 45 59 ml/min/1.73 m2 and an eGFRcystatinC of more than 60 ml/min/1.73 m2 and no other marker of kidney disease. Do not do July 2014 Unclassified
Do not use reagent strips to identify proteinuria unless they are capable of specifically measuring albumin at low concentrations and expressing the result as an ACR. Do not do July 2014 Unclassified
Do not use urine microscopy to confirm a reagent strip positive result when testing for the presence of haematuria. Do not do July 2014 Unclassified
Do not use age, gender or ethnicity as risk markers to test people for CKD. Do not do July 2014 Unclassified
In the absence of metabolic syndrome, diabetes or Hypertension, do not use obesity alone as a risk marker to test people for CKD. Do not do July 2014 Unclassified
Do not determine management of CKD solely by age. Do not do July 2014 Unclassified
Do not offer low-protein diets (dietary protein intake less than 0.6 0.8 g/kg/day) to people with CKD. Do not do July 2014 Unclassified
Do not offer a combination of renin angiotensin system antagonists to people with CKD. Do not do July 2014 Unclassified
Do not routinely offer a renin angiotensin system antagonist to people with CKD if their pretreatment serum potassium concentration is greater than 5.0 mmol/litre. Do not do July 2014 Unclassified
Do not routinely measure calcium, Phosphate, parathyroid hormone (PTH) and vitamin D levels in people with a GFR of 30 ml/min/1.73 m2 or more (GFR category G1, G2 or G3). Do not do July 2014 Unclassified